Have a personal or library account? Click to login
Dobutamine Stress Echocardiography in Patients with Dilated Cardiomyopathy Cover

Dobutamine Stress Echocardiography in Patients with Dilated Cardiomyopathy

Open Access
|Jun 2016

References

  1. 1. Marwick TH. The effect of coronary occlusion on myocardial contraction. In : Marwick TH, editor. Stres echocardiography 1th ed. Netherlands: Kluwer; 1994.
  2. 2. Marwick TH. Stress echocardiography. In: Topol EJ, editor. Texbook of Cardiovascular Medicine 2th ed. Philadelphia: Lippincott-Raven; 1998.
  3. 3. Sharp SM, Sawada SG, Segar DS, Ryan T, Kovasc R, Fineberg NS et al. Dobutamine stress echocardiography: Detection of coronary Artery disease in patients with dilated cardiomyopathy. J Am Cardiol 1994; 24:934-9.10.1016/0735-1097(94)90852-4
  4. 4. Sawada SG, Segar DS, Ryan T, Brown SE, Dohan AM, Williams R et al. Echocardiographic detection of coronary artery disease during dobutamin infusion Circulation 1991; 83:1605-14.
  5. 5. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994; 23:617-26.10.1016/0735-1097(94)90745-5
  6. 6. Vigna C, Russo A, De Rito V, Perna GP, Tsta M, Lombardo A et al. Regional wall moton analysis by dobutamine echocardiography to distinguish between ischemic amd nonischemic dilated cardiomyopathy. Am Heart J 1996; 131:537-43.10.1016/S0002-8703(96)90534-7
  7. 7. Pim A L, Tonino M, Bernard De Bruyne, Nico H J Pijls, Uwe S, Fumiaki I, Marcel van't Veer et al. Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention. N Engl J Med 2009; 360:213-24.10.1056/NEJMoa0807611
  8. 8. Bernard De Bruyne, Nico H J Pijls, Bindu K, Emanuele B, Pim A L T, Zsolt P et al. Fractional Flow Reserve- Guided PCI versus Medical Therapy in Stable Coronary Disease. N Engl J Med 2012; 367:991-100110.1056/NEJMoa1205361
  9. 9. Miloradović V, Otašević P, Bojić D, Popović AD. Klinički značaj dobutamin stres ehokardiografije. Ultrazvuk 1997; 5:11-17.
  10. 10. Franciosa JA, Wilen MV, Ziesche S, Cohn J. Survival in man with severe chronic left ventricular failure due to coronary artery disease or idiopatic dilated cardiomyopathy. Am J Cardiol 1983; 51:831-7.10.1016/S0002-9149(83)80141-6
  11. 11. Kruti J, Irshad A, Emily R, Irmina G P, Jothiharan M, Masoor K, Harvey F and Sawada S. Effect of improvement in left ventricular ejection fraction on long-term survival in revascularized patients with ischaemic left ventricular systolic dysfunction. European Journal of Echocardiography (2011) 12, 454-60.10.1093/ejechocard/jer045
  12. 12. Poldermans D, Elhendy A, Harvey F and Sawada S. Prognosis of patients with ischaemic cardiomyopathy after coronary revascularisation: relation to viability and improvement in left ventricular ejection fraction. Heart 2009;95:1273-77.10.1136/hrt.2008.163972
  13. 13. V Rizzello V, Poldermans D, Schinkel A F L, Biagini E, Boersma E, Elhendy A, Sozzi F B, Maat A, Crea F, Roelandt J R T C, Bax J. Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularisation. Heart 2006;92:239-244.10.1136/hrt.2004.055798
  14. 14. Medina R, Panidis IP, Morganroth J, Kotler MN, Mintz GS. The value of echocardiographic regional wall motion abnormalities in detecting coronary artery disease in patients with and without a dilated left ventricle. Am Heart J 1985; 109:799-803.10.1016/0002-8703(85)90641-6
  15. 15. Rogel VL, Pellikka PA, Oh JK, Baily KR, Tajik AJ. Identification of multivassel coronary artery disease by exercise echocardiography. J Am Coll Cardiol 1994; 24:109-14.10.1016/0735-1097(94)90549-5
  16. 16. Elhendy A, Van Donburg RT, Bax JJ, Poldermans D, Nierop PR, Geleijnse ML, Roelandt JR. The grade of worsering of regional function during dobutamine stress echocardiography predicts the extent of myocardial perfusion abnormalites. Heart 2000; 83:35-39.10.1136/heart.83.1.35
  17. 17. Kramer CM, Malkowski MJ, Mankad S, Theobald TM, Paksitis DL, Rogers WJ. Magnetic resonance tagging and echocardiographic response to dobutamine and functional improvement after reperfused myocardial infarction. Am Heart J 2002; 143:1046-51.10.1067/mhj.2002.122515
  18. 18. Diaz RA, nihoyannopoulos P, Athanassopoulos G, Oakley CM. Usefulness of echocardiography to diferentiate dilated cardiomyopathy. Am J Cardiol 1994;68:1224’7.10.1016/0002-9149(91)90199-U
  19. 19. Krahwinkel W, Ketteler T, Godke J. Dobutamine stres echocardiography. Eur Heart J 1997; 18(Suppl D):D9-15.10.1093/eurheartj/18.suppl_D.9
  20. 20. Pratali L, Picano E, Otašević P, Vigna V, Palinkas A, Cortigiani L et al. Prognostic significance of the dobutamine echocardiography test in idiopatic dilated cardiomyopathy. Am J cardiol 2001; 88:1374-8.10.1016/S0002-9149(01)02116-6
  21. 21. Jeane M T, Abdou E, James R A, Feng X, Anna C M and Thomas R P. Prognostic Value of Dobutamine Stress Myocardial Contrast Perfusion Echocardiography. Circulation. 2005;112:1444-50.10.1161/CIRCULATIONAHA.105.53713416129798
  22. 22. Squeri A, Gaibazzi N, Reverberi C, Caracciolo MM, Ardissino D and Gherli T. Ejection fraction change and coronary artery disease severity: a vasodilator contrast stress-echocardiography study. J Am Soc Echocardiogr. 2012 Apr;25(4):454-9.10.1016/j.echo.2011.12.00922243999
  23. 23. Panza J M, Laurienzo J M, Quyyumi A A and Dilsizian V. Relation Between Ischemic Threshold Measured During Dobutamine Stress Echocardiography and Known Indices of Poor Prognosis in Patients With Coronary Artery Disease. Am Heart J 1995; 122: 893-99.10.1161/01.CIR.92.8.20957554187
  24. 24. Picano E. Stress echocardiography. Springer-Verlag Berlin, Heidelberg. 2009.10.1007/978-3-540-76466-3
  25. 25. Douglas SP, Khandheria B, Stainback FR et al. ACCF/ASE/ACEP/AHA/ASNS/SCAI/SCCT/SCMR 2008, Approprietnes criteria for stress echocardiography. J Am Coll Cardiol 2008;51:1127-47.10.1016/j.jacc.2007.12.00518342240
  26. 26. Ghani A & J-H. E. Dambrink & A. W. J. van’t Hof & J. P. Ottervanger & A. T. M. Gosselink & J. C. A. Hoorntje. Treatment of non-culprit lesions detected during primary PCI: long-term follow-up of a randomised clinical trial. Neth Heart J (2012) 20:347-353 10.1007/s12471-012-0281-y343076722622701
DOI: https://doi.org/10.1515/sjecr-2016-0004 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Language: English
Page range: 125 - 132
Submitted on: Dec 21, 2015
|
Accepted on: Jan 21, 2016
|
Published on: Jun 10, 2016
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2016 Vladimir Miloradovic, Milena Grubisa, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.